Dimeric procyanidin B2 inhibits constitutively active NF-κB in Hodgkin's lymphoma cells independently of the presence of IκB mutations

Gerardo Mackenzie, Ana M. Adamo, Noah P. Decker, Patricia I. Oteiza

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Dimeric procyanidin B2 inhibits constitutively active NF-κB in Hodgkin's lymphoma cells independently of the presence of IκB mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds